O'Brien Jennifer A
KarenZupko & Associates, 625 N. Michigan Avenue, #702, Chicago, IL 60611, USA.
J Med Pract Manage. 2007 May-Jun;22(6):369-71.
The National Coverage Decision of 2000 was designed to enhance the participation in clinical trials for both patients and physicians by mandating the governmental coverage for services in a clinical trial that are considered "routine" regardless of the trial. Participation in clinical trials can be a practice builder as well as a contribution to the betterment of medical science. Without proper coverage analysis, study budgeting, accurate time estimates, and effective negotiation prior to signing the contract, participation in clinical trials can cost a practice rather than benefit it.
2000年的国家医保覆盖决策旨在通过强制政府为临床试验中被视为“常规”的服务提供医保覆盖,而不论该试验情况如何,来提高患者和医生参与临床试验的积极性。参与临床试验既可以促进业务发展,也有助于推动医学进步。如果在签订合同前没有进行适当的医保覆盖分析、研究预算编制、准确的时间估算以及有效的谈判,那么参与临床试验可能会给医疗机构带来损失而非收益。